Llusern grabs the limelight at Arab Health 2025
Study shows Lodestar DX accurately identifies uropathogens in mixed growth cultures
Llusern kicks off Series A round at BioSeed 2025
David Browning appointed as Chairman of Llusern Scientific
Llusern secures Seed Investment from DBW
Llusern’s Lodestar DX Evaluation Published in JAC-AMR: Demonstrating High Correlation with Gold Standard UTI Testing
Longitude Prize on AMR
Bio 2024, San Diego
Two abstracts published by JAC-AMR
Poster presentations at BSAC UTI conference
Llusern at ECCMID23 in Copenhagen
Women feel ‘failed’ by UTI testing system – ITV News
Llusern included in NICE early value assessment for UTI testing
Llusern win at MediWales Awards 2022
Radio 4’s Woman’s Hour talk UTIs with Llusern
Llusern wins at the Wales STEM Awards
UTI test undergoing clinical verification and validation
